Clinical investigations of medical devices play a central role in evaluating health technologies before they reach the market. However, demonstrating the clinical benefit of medical devices often remains more complex than demonstrating the efficacy of medicines.
Unlike medicines, whose effectiveness can usually be assessed through standardized randomized controlled trials, clinical investigations of medical devices must address specific challenges: rapid technological evolution, dependence on the user, variability in clinical practices, and difficulties in comparison with a reference treatment.
These characteristics explain why clinical investigations of medical devices are receiving increasing attention from European regulatory authorities within the framework of the Medical Device Regulation (EU) 2017/745 (MDR).
nhttps://health.ec.europa.eu/medical-devices-sector/new-regulations_en
Clinical Investigations of Medical Devices: Major Methodological Specificities
Clinical investigations of medical devices differ from pharmaceutical clinical trials in several important methodological aspects.
First, the nature of a medical device can make it difficult to implement randomized controlled trials. In some situations, double-blind studies are simply not feasible—for example when an implant or surgical device is used.
Second, the performance of a medical device often depends on the experience of the operator. This learning curve effect can significantly influence clinical outcomes and introduce variability that is difficult to control during clinical investigations of medical devices.
Finally, medical devices evolve rapidly. A new version of a device may appear while a clinical investigation is still ongoing, complicating the interpretation and comparison of results.
The European Commission highlights that the clinical evaluation of medical devices relies on a combination of evidence derived from:
- clinical investigations of medical devices
- scientific literature
- post-market clinical experience
https://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg_en
Demonstrating Clinical Benefit in Medical Devices
For medicines, demonstrating efficacy typically relies on well-defined clinical endpoints and rigorous comparative trials.
In contrast, clinical investigations of medical devices often face additional challenges when demonstrating clinical benefit.
First, some medical devices aim to improve a medical procedure rather than deliver a direct therapeutic effect. In such cases, the benefit may be indirect—for example by reducing procedure duration or improving the precision of a surgical gesture.
Second, evaluation criteria can be more difficult to measure. In areas such as medical imaging or digital medical devices, improvements in diagnostic performance may require complex study designs and sophisticated methodologies.
According to a report from the French National Authority for Health (HAS), the clinical evaluation of medical devices must therefore consider not only technical performance but also the real impact on patient management and clinical outcomes.
https://www.has-sante.fr/jcms/c_2817125/fr/evaluation-des-dispositifs-medicaux
Stronger Regulatory Requirements for Clinical Investigations of Medical Devices in Europe
In response to these methodological challenges, the Medical Device Regulation (EU) 2017/745 (MDR) has significantly strengthened requirements for clinical investigations of medical devices.
Manufacturers must now provide stronger clinical evidence to demonstrate:
- the safety of the device
- its clinical performance
- its benefit for patients
The regulation also reinforces requirements related to post-market surveillance and post-market clinical investigations.
https://www.ema.europa.eu/en/human-regulatory-overview/medical-devices
This regulatory evolution aims to improve the quality of clinical evidence while acknowledging the specific nature of clinical investigations of medical devices.
Clinical Investigations of Medical Devices: A Key Challenge for Healthcare Innovation
Today, clinical investigations of medical devices play a fundamental role in medical innovation.
Many emerging technologies—such as surgical robotics, digital health tools, and artificial intelligence-based medical devices—rely on medical devices whose clinical evaluation remains complex.
For stakeholders across the healthcare sector, the challenge is therefore to strike a balance between scientific rigor and methodological flexibility in order to generate robust clinical evidence without slowing technological innovation.
In this context, the evolution of the European regulatory framework and the development of new evaluation methodologies are likely to continue transforming clinical investigations of medical devices in the coming years.
